Polyethylene Glycol Exposure with Antihemophilic Factor (Recombinant), PEGylated (rurioctocog alfa pegol) and Other Therapies Indicated for the Pediatric Population: History and Safety

• 主要な著者: Reinhard Stidl (著者), Michael Denne (著者), Jimena Goldstine (著者), Bill Kadish (著者), Katherine I. Korakas (著者), Peter L. Turecek (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2018-07-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Polyethylene glycol (PEG) is an inert, water soluble polymer, used for decades in pharmaceuticals. Although PEG is considered safe, concerns persist about the potential adverse effects of long-term exposure to PEG-containing therapies, specifically in children, following the introduction of PEGylate...